Roche reports positive Phase III data for breast cancer therapy

Roche reports positive Phase III data for breast cancer therapy

Source: 
Clinical Trials Arena
snippet: 

Swiss pharmaceutical company Roche has reported positive data from the Phase III INAVO120 clinical trial of its investigational therapy, inavolisib, alongside palbociclib (Ibrance) and fulvestrant to treat locally advanced or metastatic breast cancer.